title: Immunomodulating effects of extracorporeal photochemotherapy in rat experimental allergic encephalomyelitis.
abstract: Experimental allergic encephalomyelitis (EAE) is a well-established model of human multiple sclerosis that is commonly used to evaluate the possible effectiveness of new treatments in this disease. Extracorporeal photochemotherapy (ECP) is an immunomodulating procedure currently used in several non-neurological diseases that, like multiple sclerosis, are likely to be due to T-cell-mediated autoimmunity. In this study we examined the effect of ECP using the EAE paradigm in the Lewis rat. In our model, ECP induced a significant modulation in peripheral blood T-cell distribution, changes which are typical of EAE. Remarkably, this effect was closely correlated with the clinical and pathological results, which showed reduced severity of the disease in the ECP-treated EAE animals vs. the EAE alone rats. We conclude that ECP induces modifications in the immunological events that occur during the course of EAE in rats, thus giving support to the hypothesis that it could be used in the treatment of multiple sclerosis.
authors.affiliation: Department of Neuroscience, University of Milan Bicocca, Neurologic Unit, S. Gerardo Hospital, Monza, Italy. guido.cavaletti@unimi.it
authors.forename: G
authors.initials: G
authors.lastname: Cavaletti
authors.forename: P
authors.initials: P
authors.lastname: Perseghin
authors.forename: F
authors.initials: F
authors.lastname: Buscemi
authors.forename: M
authors.initials: M
authors.lastname: Dassi
authors.forename: N
authors.initials: N
authors.lastname: Oggioni
authors.forename: F
authors.initials: F
authors.lastname: Sala
authors.forename: F
authors.initials: F
authors.lastname: Lolli
authors.forename: G M
authors.initials: GM
authors.lastname: Liuzzi
authors.forename: P
authors.initials: P
authors.lastname: Riccio
authors.forename: L
authors.initials: L
authors.lastname: Frattola
authors.forename: G
authors.initials: G
authors.lastname: Tredici
mesh_terms: D000276:Adjuvants, Immunologic; D000818:Animals; D015496:CD4-Positive T-Lymphocytes / Q000166:cytology; D018414:CD8-Positive T-Lymphocytes / Q000166:cytology; D004681:Encephalomyelitis, Autoimmune, Experimental / Q000188:drug therapy / Q000276:immunology* / Q000473:pathology / Q000503:physiopathology; D005260:Female; D018655:Lymphocyte Count; D008730:Methoxsalen / Q000627:therapeutic use; D017893:Photopheresis / Q000379:methods; D051381:Rats; D011917:Rats, Inbred Lew; D016896:Treatment Outcome
chemical_list: D000276:Adjuvants, Immunologic; D008730:Methoxsalen